Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.471
+0.013 (2.73%)
At close: Mar 9, 2026, 4:00 PM EDT
0.465
-0.006 (-1.32%)
After-hours: Mar 9, 2026, 7:10 PM EDT
Klotho Neurosciences Employees
Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.
Employees
3
Change
2
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$3,763,354
Market Cap
50.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | 2 | 200.00% |
| Dec 31, 2022 | 1 | -2 | -66.67% |
| Dec 31, 2021 | 3 | 2 | 200.00% |
| Dec 31, 2011 | 1 | 0 | - |
| Dec 31, 2010 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 102 |
| Acrivon Therapeutics | 78 |
| Kezar Life Sciences | 55 |
| Atara Biotherapeutics | 38 |
| LeonaBio | 26 |
| MiNK Therapeutics | 23 |
| Plus Therapeutics | 21 |
| Nutriband | 13 |
KLTO News
- 5 days ago - KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR - PRNewsWire
- 13 days ago - Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI) - PRNewsWire
- 19 days ago - Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence - PRNewsWire
- 2 months ago - Klotho Neurosciences to Present at the Biotech Showcase 2026 - PRNewsWire
- 4 months ago - Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award - PRNewsWire
- 5 months ago - Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston - PRNewsWire
- 5 months ago - Klotho Neurosciences Announces Expiration of Letter of Intent - PRNewsWire
- 5 months ago - Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership - PRNewsWire